Skip Navigation

United States Department of Health & Human Services
line

Print Print    Download Reader PDF

 

The National Vaccine Advisory Committee (NVAC)

Pandemic Influenza Working Group
Marriott Hotel Century Center
Atlanta, Georgia

June 15-16, 2005

Agenda

Time

Topic

Presenter

Wednesday, June 15, 2005

8:30 am

Introductions, housekeeping, and starting assumptions
   Vaccine Subgroup [PPT - 1.4MB]
   Antiviral Subgroup [PPT - 288KB]


Bridges
Schwartz

9:00 am

Report from impact subgroup [PPT - 397KB]
-Impact of 3 pandemics and possible sub-prioritization of specific groups

9:45 am

Reports from healthcare worker subgroup [PPT - 120KB]

10:30 am

- Break -

10:45 am

Report from critical infrastructure work group [PPT - 162KB]

11:30 am

Report from ethics work group [PPT - 97KB]

12:00 pm

- Lunch -

NVAC/ACIP Vaccine Subgroup

Wednesday, June 15, 2005

1:00 pm

Additional information on possible vaccination strategies

a. Effectiveness of vaccinating pregnant women in protecting infants <6 months

Marika Iwane

b. Recent data from Texas studies on impact of vaccinating school-aged children [PPT - 1.3MB]

Paul Glezen

c. Review of prior modeling studies on influenza vaccination of children [PPT - 327KB]

Martin Meltzer

Additional discussion

2:00 pm

Discussion of assumptions for prioritization

2:30 pm

- Break -

2:45 pm

Options and discussion of priority groups for influenza vaccine

5:00 pm

- Adjourn for evening -

Thursday, June 16, 2005

8:30 am

Report from Antivirals Sub-group [PPT - 310KB]

Ben Schwartz

9:00 am

Continued discussion from previous day
- begin drafting prioritization list

10:30 am

- Break -

10:45 am

Continued drafting of prioritization list

12:00 pm

- Working Lunch -

1:00 pm

Finalize drafting

3:00 pm

Discussion of unresolved issues and additional data needs

  • Timelines and mechanisms for drafting formal report and
    communicating summary to the ACIP and NVAC

4:00 pm

- Adjourn -

NVAC Antivirals Subgroup

Wednesday, June 15, 2005

1:00 pm

Report on antivirals and H5N1 cases in Asia [PPT - 5.01MB]

Fukuda

1:30 pm

Report on animal models, H5N1, and oseltamivir [PPT - 5.08MB]

Monto

2:00 pm

Discussion

2:15 pm

Comments from Roche and supply issues

McGuire

2:30 pm

- Break -

2:45 pm

Report on antivirals from the London modeling meeting

Schwartz

3:15 pm

Discussion of draft strategies and priority groups

Thursday, June 16, 2005

8:30 am

Report on the CDC antiviral plan [PPT - 284KB]

Shay

9:00 am

Report on implementing a response in Wisconsin [PPT - 268KB]

Haupt

9:30 am

Discussion

10:00 am

- Break-

10:15 am

Continued discussion of priorities and implementation

12:00 pm

- Working Lunch -

1:00 pm

Continued discussion, as needed, next steps

3:00 pm

- Adjourn -

Last revised: March 31, 2006

spacer

HHS Home | Questions? | Contact HHS | Accessibility | Privacy Policy | FOIA | Disclaimers

The White House | USA.gov | Helping America's Youth | HHS Archive